SOURCE: Velocity International Corp.

January 24, 2006 09:25 ET

Velocity International Contracts Key Strategic Consultant Firm

NASHVILLE, TN -- (MARKET WIRE) -- January 24, 2006 -- Velocity International Corporation (OTC: VCYI) announces that GDR International Inc. has been contracted to assist management in the development and execution of strategic planning, recruitment of key management, patent protection, FDA relations, government relations, international relations, private placements, and to identify private consultants and consulting groups for its wholly owned subsidiary Deep Blue, Inc.

GDR International Inc. (GDRI), headquartered in New York, NY, focuses on providing a wide range of strategic services to the health care industry. GDRI's client base ranges from the biotechnology and pharmaceutical industries. They include reagent manufacturers, diagnostic testing equipment companies, sports nutrition, and weight loss companies among others. The GDRI management team has over 60 years of combined experience in senior management positions with Fortune 100 companies. GDRI management has also been instrumental in the development of start up and early stage companies. The GDRI team has a broad and successful track record in identifying opportunities and helping to develop or refocus them into successful businesses. Additionally the team at GDRI has extensive experience in corporate development and strategic partnering.

Michael McCarthy, the project manager, has been involved in sustenance and health science for the last three years working on proprietary and patent technologies. He has over twenty-five years of management experience. He is the former Vice President of Pepsi-Cola, Fountain Solutions and is also the CEO of Russell Simmons Food and Beverage Company, a joint venture that he negotiated between NXT LLC and the legendary Hip Hop and fashion mogul. He stated, "That the GDRI team has completed their due diligence and believes this will be the most dynamic project that his team has undertaken."

The European liaison is Charles Gregoire de Rothschild; he is responsible for EU market development, institutional investor relations, and the development of key European medical center relationships. Mr. Rothschild declared, "That GDR International can and will bring considerable financial guidance and support to help make Deep Blue the health care leader in its field." He has an extensive background in Merchant Banking in the US & in Europe for over three decades. He has served as Director & Chairman of several companies including AB International Investors, Summit Holdings, and MDR Realty.

Velocity International Corp. and its wholly owned subsidiary Deep Blue, Inc. (http://www.deepblueinc.com/) are bringing to market a new patent-pending treatment, (Application Number 11/208,402), for HIV /AIDS and other viral infectious diseases.

Cautionary Statement:

This news release may contain certain forward-looking statements within the meaning of Section 27A of the Securities and Exchange Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties. Although Velocity International Corp. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any assumption could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included herein, the inclusion should not be regarded as a representation by Velocity International Corp., or any other person that the objectives and plans of Velocity International Corp. will be achieved.

Contact Information

  • Contact:
    Michael Young
    (216) 702-1468